Abstract
Background
There is an ongoing debate on the role of corticosteroids in the treatment of chronic subdural hematoma (CSDH). This study aims to evaluate the effectiveness of corticosteroids for the treatment of CSDH compared to surgery.
Method
A systematic search was performed in relevant databases up to January 2019 to identify RCTs or observational studies that compared at least two of three treatment modalities: the use of corticosteroids as a monotherapy (C), corticosteroids as an adjunct to surgery (CS), and surgery alone (S). Outcome measures were good neurological outcome, need for reintervention, mortality, and complications. Effect estimates were pooled and presented as relative risk (RR) with 95% confidence interval (95%CI).
Results
Of 796 initially identified studies, 7 were included in the meta-analysis. Risk of bias was generally high. There were no differences in good neurological outcome between treatment modalities. The need for reintervention varied between 4 and 58% in C, 4–12% in CS, and 7–26% in S. The need for reintervention was lower in CS compared with C (RR 3.34 [95% CI 1.53–7.29]; p < 0.01) and lower in CS compared with S (RR 0.44 [95% CI 0.27–0.72]; p < 0.01). Mortality varied between 0 and 4% in C, 0–13% in CS, and 0–44% in S. Mortality was lower in CS compared with S (RR 0.39 [95% CI 0.25–0.63]; p < 0.01). There were no differences in complications between treatment modalities.
Conclusions
This meta-analysis suggests that the addition of corticosteroids to surgery might be effective in the treatment of CSDH. However, the results must be interpreted with caution in light of the serious risk of bias of the included studies. This study stresses the need for large randomized trials to investigate the use of corticosteroids in the management of CSDH.
Similar content being viewed by others
References
Adhiyaman V, Asghar M, Ganeshram KN, Bhowmick BK (2002) Chronic subdural haematoma in the elderly. Postgrad Med J 78:71–75
Adhiyaman V, Chattopadhyay I, Irshad F, Curran D, Abraham S (2017) Increasing incidence of chronic subdural haematoma in the elderly. QJM 110:375–378
Almenawer SA, Farrokhyar F, Hong C, Alhazzani W, Manoranjan B, Yarascavitch B, Arjmand P, Baronia B, Reddy K, Murty N, Singh S (2014) Chronic subdural hematoma management: a systematic review and meta-analysis of 34,829 patients. Ann Surg 259:449–457
Asghar M, Adhiyaman V, Greenway MW, Bhowmick BK, Bates A (2002) Chronic subdural haematoma in the elderly--a North Wales experience. J R Soc Med 95:290–292
Aspegren O, Astrand R, Lundgren M, Romner B (2013) Anticoagulation therapy a risk factor for the development of chronic subdural hematoma. Clin Neurol Neurosurg 115:981–984
Baechli H, Nordmann A, Bucher HC, Gratzl O (2004) Demographics and prevalent risk factors of chronic subdural haematoma: results of a large single-center cohort study. Neurosurg Rev 27:263–266
Balser D, Farooq S, Mehmood T, Reyes M, Samadani U (2015) Actual and projected incidence rates for chronic subdural hematomas in United States Veterans Administration and civilian populations. J Neurosurg 123:1209–1215
Baschera D, Tosic L, Westermann L, Oberle J, Alfieri A (2018) Treatment standards for chronic subdural hematoma: results from a survey in Austrian, German, and Swiss neurosurgical units. World Neurosurg 116:e983–e995
Bender MB, Christoff N (1974) Nonsurgical treatment of subdural hematomas. Arch Neurol 31
Berghauser Pont LM, Dirven CM, Dippel DW, Verweij BH, Dammers R (2012) The role of corticosteroids in the management of chronic subdural hematoma: a systematic review. Eur J Neurol 19:1397–1403
Berghauser Pont LM, Dippel DW, Verweij BH, Dirven CM, Dammers R (2013) Ambivalence among neurologists and neurosurgeons on the treatment of chronic subdural hematoma: a national survey. Acta Neurol Belg 113:55–59
Brotis AG, Gatos C, Fountas KN (2018) Letter to the editor regarding “dexamethasone for chronic subdural haematoma: a systematic review and meta-analysis”. Acta Neurochir 160:2145–2147
Cenic A, Bhandari M, Reddy K (2005) Management of chronic subdural hematoma: a national survey and literature review. Can J Neurol Sci 32:501–506
Chan DYC, Sun TFD, Poon WS (2015) Steroid for chronic subdural hematoma? A prospective phase IIB pilot randomized controlled trial on the use of dexamethasone with surgical drainage for the reduction of recurrence with reoperation. Chin Neurosurg J 1:2
Delgado-López PD, Martín-Velasco V, Castilla-Díez JM, Rodríguez-Salazar A, Galacho-Harriero AM, Fernández-Arconada O (2009) Dexamethasone treatment in chronic subdural haematoma. Neurocirugía 20:346–359
Dran G, Berthier F, Fontaine D, Rasenrarijao D, Paquis P (2007) Efficacité de la corticothérapie dans le traitement adjuvant des hématomes sous-duraux chroniques. Étude rétrospective sur 198 cas. Neurochirurgie 53:477–482
Edlmann E, Giorgi-Coll S, Whitfield PC, Carpenter KLH, Hutchinson PJ (2017) Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy. J Neuroinflammation 14:108
Ernestus R, Beldzinski P, Lanfermann H, Klug N (1997) Chronic subdural hematoma: surgical treatment and outcome in 104 patients. Surg Neurol 48:220–225
Foelholm R, Waltimo O (1975) Epidemiology of chronic subdural haematoma. Acta Neurochir 32:247–250
Fountas K, Kotlia P, Panagiotopoulos V, Fotakopoulos G (2019) The outcome after surgical vs nonsurgical treatment of chronic subdural hematoma with dexamethasone. Interdiscip Neurosurg Adv Tech Case Manag 16:70–74
Gabarrós A, Acebes JJ, Rodríguez R, Cabiol J, Obarrio LL, Mamov A, Isamat F (2000) Resultados del tratamiento quirúrgico del hematoma subdural crónico. Comparación de dos técnicas: minitrépano y drenaje cerrado continuo versus dos trépanos y drenaj e externo abierto. Neurocirugía 11:377–390
Gelabert-González M, Fernández-Villa JM, López-García E, García-Allut A (2001) Hematoma subdural crónico en el paciente mayor de 80 años. Neurocirugía 12:325–330
Gelabert-Gonzalez M, Iglesias-Pais M, Garcia-Allut A, Martinez-Rumbo R (2005) Chronic subdural haematoma: surgical treatment and outcome in 1000 cases. Clin Neurol Neurosurg 107:223–229
Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JAC (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ:d5928
Holl DC, Volovici V, Dirven CMF, Peul WC, van Kooten F, Jellema K, van der Gaag NA, Miah IP, Kho KH, den Hertog HM, Lingsma HF, Dammers R, Dutch Chronic Subdural Hematoma Research G (2018) Pathophysiology and non-surgical treatment of chronic subdural hematoma: from past to present to future. World Neurosurg 116:402–411 e402
Holl DC, Volovici V, Dirven CM, Van Kooten F, Miah IP, Jellema K, Peul WC, Van der Gaag NA, Kho KH, Den Hertog HM, Dammers R, Lingsma HF (2019) PROSPERO record: corticosteroid treatment compared to surgery in chronic subdural hematoma: a systematic review and meta-analysis. https://www.crd.york.ac.uk/prospero. Registration number CRD42019123594; last edited 27/03/2019
Jennett B, Bond M (1975) Assessment of outcome after severe brain damage. Lancet 1:480–484
Jung Y, Jung N, Kim E (2015) Independent predictors for recurrence of chronic subdural hematoma. J Korean Neurosurg Soc 57:266–270
Karibe H, Kameyama M, Kawase M, Hirano T, Kawaguchi T, Tominaga T (2011) Epidemiology of chronic subdural hematomas. No Shinkei Geka 39:1149–1153
Kirley K, Qato D, Kornfield R, Stafford R, Alexander G (2012) National trends in oral anticoagulant use in the United States, 2007 to 2011. Circ Cardiovasc Qual Outcomes 5:615–621
Ko BS, Lee JK, Seo BR, Moon SJ, Kim JH, Kim SH (2008) Clinical analysis of risk factors related to recurrent chronic subdural hematoma. J Korean Neurosurg Soc 43:11–15
Kudo H, Kuwamura K, Izawa I, Sawa H, Tamaki N (1992) Chronic subdural hematoma in elderly people: present status on Awaji Island and epidemiological prospect. Neurol Med Chir (Tokyo) 32:207–209
Kwon T, Park Y, Lim D et al (2000) Chronic subdural hematoma: evaluation of the clinical significance of postoperative drainage volume. J Neurosurg 93:796–799
Lindvall P, Koskinen L (2009) Anticoagulants and antiplatelet agents and the risk of development and recurrence of chronic subdural haematomas. J Clin Neurosci 16:1287–1290
Markwalder TM, Steinsiepe KF, Rohner M, Reichenbach W, Markwalder H (1981) The course of chronic subdural hematomas after burr-hole craniostomy and closed-system drainage. J Neurosurg 55:390–396
Mellergard P, Wisten O (1996) Operations and re-operations for chronic subdural haematomas during a 25-year period in a well defined population. Acta Neurochir 138:708–713
Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097
Mori K, Maeda M (2001) Surgical treatment of chronic subdural hematoma in 500 consecutive cases: clinical characteristics, surgical outcome, complications, and recurrence rate. Neurol Med Chir (Tokyo) 41:371–381
Oishi M, Toyama M, Tamatani S, Kitazawa T, Saito M (2001) Clinical factors of recurrent chronic subdural hematoma. Neurol Med Chir (Tokyo) 41:382–386
Pichert G, Henn V (1987) Conservative therapy of chronic subdural hematomas. Schweiz Med Wochenschr 117
Prud'homme M, Mathieu F, Marcotte N, Cottin S (2016) A pilot placebo controlled randomized trial of dexamethasone for chronic subdural hematoma. Can J Neurol Sci 43:284–290
Qian Z, Yang D, Sun F, Sun Z (2017) Risk factors for recurrence of chronic subdural hematoma after burr hole surgery: potential protective role of dexamethasone. Br J Neurosurg 31:84–88
Robinson R (1984) Chronic subdural hematoma: surgical management in 133 patients. J Neurosurg 61:263–268
Santarius T, Hutchinson P (2004) Chronic subdural haematoma: time to rationalize treatment? Br J Neurosurg 18:328–332
Santarius T, Lawton R, Kirkpatrick PJ, Hutchinson PJ (2008) The management of primary chronic subdural haematoma: a questionnaire survey of practice in the United Kingdom and the Republic of Ireland. Br J Neurosurg 22:529–534
Sterne JAC, Hernan MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR, Chan AW, Churchill R, Deeks JJ, Hrobjartsson A, Kirkham J, Juni P, Loke YK, Pigott TD, Ramsay CR, Regidor D, Rothstein HR, Sandhu L, Santaguida PL, Schunemann HJ, Shea B, Shrier I, Tugwell P, Turner L, Valentine JC, Waddington H, Waters E, Wells GA, Whiting PF, Higgins JPT (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919
Sun TF, Boet R, Poon WS (2005) Non-surgical primary treatment of chronic subdural haematoma: preliminary results of using dexamethasone. Br J Neurosurg 19:327–333
Thotakura AK, Marabathina NR (2015) Nonsurgical treatment of chronic subdural hematoma with steroids. World Neurosurg 84:1968–1972
Torihashi K, Sadamasa N, Yoshida K et al (2008) Independent predictors for recurrence of chronic subdural hematoma: a review of 343 consecutive surgical cases. Neurosurgery 63:1125–1129
Turgut M, Akhaddar A (2017) Dexamethasone for chronic subdural hematoma: a systematic review and meta-analysis. Acta Neurochir 159:2289–2290
Vasella F, Akeret K, Smoll NR, Germans MR, Jehli E, Bozinov O, Regli L, Stienen MN, group CSs (2018) Improving the aesthetic outcome with burr hole cover placement in chronic subdural hematoma evacuation-a retrospective pilot study. Acta Neurochir 160:2129–2135
Victoratos G, Bligh A (1981) A more systematic management of subdural hematoma with the aid of CT scan. Surg Neurol 15:158–160
Voelker JL (2000) Nonoperative treatment of chronic subdural hematoma. Neurosurg Clin N Am 11:507–513
Yao Z, You C (2017) Reply to letter: “dexamethasone for chronic subdural haematoma: a systematic review and meta-analysis”. Acta Neurochir 159:2291
Yao Z, Hu X, Ma L, You C (2017) Dexamethasone for chronic subdural haematoma: a systematic review and meta-analysis. Acta Neurochir 159:2037–2044
Zhang Y, Chen S, Xiao Y, Tang W (2017) Effects of dexamethasone in the treatment of recurrent chronic subdural hematoma. World Neurosurg 105:115–121
Acknowledgements
The authors would like to thank Wichor M. Bramer, information specialist at the Erasmus Medical Centre in Rotterdam, The Netherlands, for his assistance in the literature search. The authors are part of the Dutch Chronic Subdural Hematoma Research group (DSHR); which aims to unite Dutch CSDH-researchers.
Funding
The Netherlands Organisation for Health Research and Development (ZonMw project number 843002824) provided financial support in the form of funding. The sponsor had no role in the design or conduct of this research.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
Ethical approval
For this type of study formal consent is not required. This article does not contain any studies with human participants performed by any of the authors.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Dana C. Holl and Victor Volovici are shared first author
This article is part of the Topical Collection on Brain trauma
Rights and permissions
About this article
Cite this article
Holl, D.C., Volovici, V., Dirven, C.M.F. et al. Corticosteroid treatment compared with surgery in chronic subdural hematoma: a systematic review and meta-analysis. Acta Neurochir 161, 1231–1242 (2019). https://doi.org/10.1007/s00701-019-03881-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00701-019-03881-w